跳至主要內容
TradingPilot
績效
佈景主題
登入

新聞與行事曆

新聞: 截至 2026-10-15
這些標記是什麼意思

重要性是模型對已發布報導給出的 1–5 分，不是對市場的預測。

已排定事件列上的影響是公司顯著度層級（高/中由圖譜中心度與規模判定；低僅用於人工整理的次要事件），不是對波動幅度的預測。

標記為已確認的財報日期，是 Yahoo Finance 認定由公司確認的；預估表示尚未公布。未加標記的列沒有可查的出處記錄。

經濟數據發布屬於總體經濟、不歸屬任何產業，因此在任何檢視下都會保留。沒有數值的發布表示尚未公布，頁面會直說，而不是顯示為零。

涵蓋被追蹤公司的即將到來的事件；已過去的事件會歸檔，並在可得時補上結果——這些結果都經人工整理並附引用，絕不杜撰。沒有結果的歷史列會顯示「結果待定」。

閉鎖期屆滿或指數調整的列會多出一行算術——將變得可賣出的股數，或指數基金必須買進的股數，以佔流通股的比例表示——依招股說明書或指數編製方法讀出，兩個數字都在該列註明出處。它陳述的是機制，不是價格走勢。由 IPO + 180 天推算出的閉鎖期日期會一直標為預估，直到公司自己說明為止。

未來

已排定 · 今天與明天 · 行事曆更新於 2026-10-22

10月22日週四 · 今天

過往

已發布 · 最新在前

8月30日週日

產品

15:30
Yahoo Finance

Humana Is Cutting Medicare Advantage Plans for 2027. The Non-Renewal Letters Arrive in Early October.

Humana is cutting Medicare Advantage plans for 2027, with non-renewal letters to affected members due in early October.

大盤 開啟原文 ↗

產品

13:57
PR Newswire

NASA's Roman Space Telescope launches with BAE Systems-built scientific instruments

NASA's Roman Space Telescope launched carrying scientific instruments built by BAE Systems. No financial terms were given in the release.

文章預覽

The Nancy Grace Roman Space Telescope is the latest NASA astrophysics flagship observatory supported by BAE Systems, following Hubble and Webb BROOMFIELD, Colo. , Aug. 30, 2026 /PRNewswire/ -- BAE Systems (LON: BA) is celebrating the successful launch of NASA's Nancy Grace Roman Space Telescope today from Kennedy Space Center in Florida, which will support critical astrophysics discoveries as the latest flagship observatory. Continue Reading NASA’s Nancy Grace Roman Space Telescope launching from Kennedy Space Center (BAE Systems). BAE Systems designed and developed the Opto-Mechanical Assembl…

大盤 開啟原文 ↗

產品

13:30
Business Wire

L3Harris Celebrates Successful Launch of NASA's Nancy Grace Roman Space Telescope

L3Harris marked the successful launch of NASA's Nancy Grace Roman Space Telescope. No contract or program figures appear in the supplied text.

大盤 開啟原文 ↗

產品

12:23
Business Wire

Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings

Alnylam presented new data at ESC Congress 2026 on RNAi-powered TTR silencing across ATTR-CM patient populations and treatment settings. No figures appear in the supplied text.

大盤 開啟原文 ↗

產品

11:45
Business Wire

Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026

Bayer said its Phase III REVEAL study of the investigational PET radiotracer iodine 124 evuzamitide was presented as a late-breaker at ESC 2026. No trial figures appear in the supplied text.

大盤 開啟原文 ↗

原始消息流

所有到達的消息 · 7 天